Huma has bought Surrey-founded wellness tracking app developer Biobeats to increase the number of digital biomarkers that underpin its services.
Biobeats, a UK-based digital wellness technology company leveraging University of Surrey research, has been acquired by health technology and services provider Huma for an undisclosed sum.
Huma was known as Medopad prior to the announcement. It has also purchased Tarilian Laser Technologies, a supplier of non-invasive blood pressure monitors.
Founded in 2012, Biobeats has built a personal wellness app called BioBase that can be paired with wearable devices to monitor mental health-related biometric and psychometric markers such as heart rate.
BioBase is marketed to employers who offer the service to their employees as part of a company wellness package. It also recommends wellness treatments such as meditation and digital therapeutic programs.
Huma started out providing telemedicine-based monitoring for rare and chronic diseases but has since diversified to offer more remote health and wellness products. It will use the acquisitions to increase the number of digital biomarkers…
